Development of an In Vitro System to Study the Interactions of Aerosolized Drugs with Pulmonary Mucus
Mucus is the first biological component inhaled drugs encounter on their journey towards their pharmacological target in the upper airways. Yet, how mucus may influence drug disposition and efficacy in the lungs has been essentially overlooked. In this study, a simple in vitro system was developed t...
Saved in:
Main Authors: | Safar Alqahtani (Author), Clive J. Roberts (Author), Snjezana Stolnik (Author), Cynthia Bosquillon (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus
by: Leah Wright, et al.
Published: (2022) -
Pulmonary Mucus Gland Adenomas: Are They Always of Endobronchial Localization?
by: Georgia Karpathiou, et al.
Published: (2013) -
Developments of mucus penetrating nanoparticles
by: Min Liu, et al.
Published: (2015) -
The Interaction of Large Bowel Microflora with the Colonic Mucus Barrier
by: Jeffrey P. Pearson, et al.
Published: (2010) -
Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment
by: Binay Kumar Shah, et al.
Published: (2023)